Search

everythinglearnresearchcommunity

for

Search:↓

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

The plant extracts may help treat hair loss by promoting hair growth and reducing DHT levels.

An extremely low-birthweight infant had a rare genetic skin disease and died despite treatment.

N6-methyladenosine affects hair follicle development differently in Rex and Hycole rabbits.

Blocking EGFR can lead to hair loss due to inflammation and stem cell damage.

Disrupting a specific protein's function in hair follicle stem cells triggers their activation and a self-healing process.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

EGFR is crucial for preventing hair follicle inflammation and hair loss.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.

Drug repurposing shows promise for treating many medical conditions.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

Cross-section trichometry is an accurate method to measure hair loss and growth.

Certain gene variations may increase the risk of alopecia, and platelet-rich plasma treatment can improve hair density in those with hair loss; a rare case of facial Becker's nevus was linked to uneven beard growth.

Certain gene variations might increase the risk of a hair loss condition in Koreans.

Scientists found key proteins and genes that affect skin and hair health, and identified potential new treatments for hair loss, skin disorders, and wound healing.

Epimorphin helps shape and develop epithelial cells, like those in hair follicles.

Platycladi Cacumen may help treat hair loss by targeting specific proteins and pathways.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

Erlotinib can cause excessive eyelash growth.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

EGFR inhibitors can cause unusual localized hair growth.

Cetuximab can cause skin cysts after acne-like eruptions.

Hair is important for aging and cancer treatment, affecting emotions, culture, and health.

Genetic testing for EGFR mutations is crucial in similar cases.

Collagen XVII is crucial for skin cell growth and nail health.